Journals / Medical Science and Discovery / 2018 / Cilt: 5 Sayı: 8

An investigation of inappropriate medication use and dangerous drug combinations in elderly patients with polypharmacy

Pages
295–302
Publication Date
2018-08-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presentations to hospital caused by drug-drug interactions most commonly involve dyspnea and bleeding, and a higher number of drugs increase rates of DDC development and numbers of hospital presentations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Polypharmacy is common among the elderly patients.
📊
Key Findings & Data:Methods: This prospective study was performed with elderly patients aged over 65.
💡
Conclusion & Impact:Presentations to hospital caused by drug-drug interactions most commonly involve dyspnea and bleeding, and a higher number of drugs increase rates of DDC development and numbers of hospital presentations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Emergency department · medicine · elderly

Abstract

Objective: Polypharmacy is common among the elderly patients. The aim of this study was to determine drugs used inappropriately in elderly with polypharmacy or causing a dangerous drug combination (DDC) and to investigate the relation between drug interaction and emergency department (ED) presentation symptoms. Methods: This prospective study was performed with elderly patients aged over 65. Patients’ demographic characteristics, presentation symptoms, comorbid diseases, and the names, numbers, dosages and side-effect of drugs used were recorded. Results: DDC was present in 94.6% of patients, and 24.3% presented to the ED with drug interaction-related symptoms. The mean age of the patients with DDCs was 72.4±6.7 years, 68.3±5.5 years among those without DDC(p=0.016).The most common comorbid disease was hypertension(75.1%), the most commonly used drug group was anti arrhythmics (15.4%),and the most commonly used medication was aspirin(6.5%). The relation was observed between drug interaction-related presentation symptoms and coronary artery disease (CAD) (p=0.044). Correlation was determined between DDC and the anti-hypertensive drug group (p<0.001).Correlation was determined between drug interaction and subjects with presentation symptoms of dyspnea and bleeding (p<0.001 and p<0.001, respectively). Numbers of drugs used and frequency of presentation to hospital were higher in patients with DDCs (p<0.001; 0.040 respectively).Positive correlation was determined between frequency of presentation and number of drugs used(r: 0.514; p <0.001). Conclusion: DDCs are more common as age increases in elderly. This situation especially remarkable in subjects with CAD and antihypertensive drugs users. Presentations to hospital caused by drug-drug interactions most commonly involve dyspnea and bleeding, and a higher number of drugs increase rates of DDC development and numbers of hospital presentations.

🔖

Cite This Article

BALTACİOGLU, H., EROGLU, O., COSKUN, F. (2018). An investigation of inappropriate medication use and dangerous drug combinations in elderly patients with polypharmacy. Medical Science and Discovery, Cilt: 5 Sayı: 8, 295–302. https://ajindex.com/articles/1003005

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Yerli G. Yaşlılık dönemi özellikleri ve yaşlılara yönelik sosyal hizmetler Journal of International Social Research. 2017;10(52):1278-87
  2. Mandiracioglu A. Demographic characteristics of the elderly population in Turkey and the world Ege Journal of Medicine. 2010;49(3):39-45
  3. Organization WH. World report on ageing and health. Geneva: WHO World Health Organization; 2015
  4. Midlöv P, Eriksson T, Kragh A. Drug-related Problems in the Elderly: Springer Science & Business Media; 2009
  5. Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM-d. The development of polypharmacy. A longitudinal study. Family practice. 2000;17(3):261-7
  6. Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Archives of internal medicine. 2004;164(18):1957-9
  7. Saraf AA, Petersen AW, Simmons SF, Schnelle JF, Bell SP, Kripalani S, et al. Medications associated with geriatric syndromes and their prevalence in older hospitalized adults discharged to skilled nursing facilities. Journal of hospital medicine. 2016;11(10):694-700
  8. MacKinnon NJ, Helper CD. Indicators of preventable drug-related morbidity in older adults. Journal of Managed Care Pharmacy. 2003;9(2):134-41
  9. Counsell SR. 2015 updated AGS Beers Criteria offer guide for safer medication use among older adults. Journal of gerontological nursing. 2015;41(11):60-1
  10. Imatani RJ. Fractures of the scapula: a review of 53 fractures. J Trauma. 1975;15(6):473-8
  11. Lu WH, Wen YW, Chen LK, Hsiao FY. Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. Canadian Medical Association Journal. 2015;187(4):E130-E7
  12. Chen YC, Huang HH, Fan JS, Chen MH, Hsu TF, Yen DHT, et al. Comparing characteristics of adverse drug events between older and younger adults presenting to a Taiwan emergency department. Medicine. 2015;94(7):1-6
  13. Sayir CT, Toprak DE, Karaoglu SA. Evaluation of polypharmacy and complementary therapy use in patients>= 65 years, attending to Family Medicine Outpatient Clinic of Şişli Etfal Training and Research Hospital. Turkish Journal of Family Practice. 2014;18(1):35-41
  14. Sonmez Y, Ucku R, Kitay S, Korkut H, Surucu S, Sezer M, et al. Quality of life and the factors affecting it among people aged 75 years and over living in a health center region in Izmir. Dokuz Eylul Universitesi Tip Fakultesi Dergisi. 2007;21(3):145-53
  15. Topbas M, Yaris F, Can G. Do the elderly have adequate information ab